Hemodialysis Market: By Type (Conventional, Daily, Nocturnal), Product (Equipment, Consumable, Drug, catheters), By Services (In-center dialysis, Home dialysis), By End User (Hospitals, Dialysis Centers), and Geography


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Hemodialysis Market size was valued at USD 74.14 billion in 2021, growing at a CAGR of 6.9% during the forecast period 2022-28. The increase in prevalence of kidney failure and chronic renal dysfunction cases. Hemodialysis is a dialysis procedure that filters a patient's blood to eliminate waste products such urea, creatinine, and excess water. These impurities typically emerge when the kidneys fail or are damaged. Companies in this field generally manufacture dialyzers and dialysis pumping machines, although they can also make other dialysis-related tools like blood pumps, catheters, and tubing kits. Moreover, increase in incidence of hypertension and diabetes, increase in government investments in healthcare, less availability of kidneys for transplantation, and the increase in the awareness about hemodialysis devices and services are the major factors that are driving the growth of the global hemodialysis market over the forecast timeframe. This report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analysed global  market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities).

Hemodialysis Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Asia Pacific
Hemodialysis Market Dynamics

Increase in the prevalence of kidney failure and chronic renal dysfunction cases is a key factor drive the global hemodialysis market. According to World Health Organization, developed countries spend more than 2–3% of their annual health-care budget on the treatment of end-stage kidney disease. According to national kidney foundation US, 10% of the population worldwide is affected by chronic kidney disease. Moreover, the advancements in the healthcare sector, raise in funding for the R&D activities by public and private sectors and increasing government funding in the establishments of new dialysis centers are anticipated to propel the global hemodialysis market over the forecast years.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2015-2020) and forecast (2021-2027).
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments and start up’s details that are actively working in the market.
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario.
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market.

Hemodialysis Market Segmentation

By Type
  • Conventional (3 times per week)
  • Daily (6 days a week)
  • Nocturnal (3-6 nights per week)
By Product
  • Equipment
  • Consumable
  • Drug
By Services
  • In-center dialysis
  • Home dialysis
By End User

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  • Fresenius Medical Care AG & Co. KGaA (Germany)
  • DaVita Healthcare Partners, Inc. (US)
  • Baxter International, Inc. (US)
  • Cantel Medical Corporation (US)
  • NIKKISO CO., LTD (Japan)
  • Dialife Group (Switzerland)
  • Braun Melsungen AG (Germany)
  • Diaverum Healthcare Partners (Germany)
  • Asahi Kasei Corporation (Japan)
  • Medtronic Plc (Ireland)
  • NxStage Medical, Inc. (US).